|
Hybrid Therapy Aims to Re-establish
Neuromuscular Balance RBy
Dr. Richard M.
Cleland
Frozen shoulder syndrome (FSS), or
adhesive capsulitis, is commonly used as the clinical
diagnosis of choice for most painful shoulder conditions that
are associated with a global loss of motion of the
glenohumeral joint. However, given the degree of movement that
is lost, it is interesting to note that FSS is rarely the
result of any serious underlying pathology. Grubbs’ definition
of frozen shoulder syndrome is “a soft tissue capsular lesion
accompanied by painful and restricted active and passive
motion at the glenohumeral joint.”(1,2)
The onset of
FSS is usually preceded by a physically traumatic event,
followed by a period of time where the shoulder joint becomes
progressively more restricted and painful. However, in a
significant number of cases, no specific physical trauma can
be attributed to the shoulder’s dysfunction. Recent statistics
suggest that FSS affects from 2 to 5% of the population, with
a female:male ratio of 60:40.(1,2,4-7) Up to 15% of patients
will experience FSS bilaterally. The most prevalent age group
appears to be between 40 and 60 years, and FSS is five times
more common in diabetics.(3) Given the somewhat idiopathic
nature of FSS, several theories have been proposed to explain
its origin.(1,3,8) Hormonal, genetic and autoimmune theories
have been suggested, but are difficult to prove to date. The
most likely theory to explain the underlying cause is postural
deviation – the most convincing study has indicated that
“long-standing round-shouldered posture causes a shortening of
the shoulder ligaments, which then makes the patient
predisposed to FSS.”(4-6)
Given the above information,
any therapy which could address the neuromuscular component of
the glenohumeral joint may be deemed appropriate. Trigenics®,
a revolutionary new neuromuscular therapy, has emerged as a
perfect option to provide treatment for this syndrome.
Trigenics® is a hybrid therapy, combining the benefits of three
already well-established treatment protocols: soft-tissue
manipulation, biofeedback and acupuncture meridian therapy.
The goal of Trigenics® is to restore the proper “tone” of any
given muscle, thereby re-establishing a correct neuromuscular
balance, and better strength-tension relationships for optimum
muscular contraction. The result is not only a muscle that
responds appropriately to its neurological signal, but also
restored joint biomechanics, as the joint must rely upon the
surrounding muscles for movement. Finally, with an additional
effect on the mind-body connection (by using influential
acupuncture meridian points during its application), the
amazing results that are achieved by using Trigenics® may be
due to its more “holistic” approach to health and healing.
Patients are often obtaining dramatic reductions in pain and
incredible improvements in their conditions where other forms
of therapy have failed.
|
|
Using a model, Dr. Cleland demonstrates a Trigenics®
Lengthening procedure for anterior deltoid (left) and teres
minor (right).
|
Case Study: Frozen Shoulder Syndrome A
52-year-old diabetic male injured his left shoulder
after lifting an object that weighed approximately five
pounds. After receiving and examining the patient’s
X-rays, which were used to rule out any obvious
pathologies, the patient’s medical doctor diagnosed him
with frozen shoulder syndrome. The patient was
prescribed pain medication and physiotherapy. After six
to seven months of physiotherapy, the patient expressed
dissatisfaction with the lack of improvement and began
to seek out new treatment options. Upon learning about
Trigenics, the patient presented to our clinic for a
trial of Trigenics® combined with chiropractic care.
In the initial examination, observation revealed
that the patient’s left shoulder was elevated at least
three inches higher than his right. Palpation of the
patient’s left shoulder revealed hypertonicity in the
upper trapezius, levator scapulae, supraspinatus,
infraspinatus, scalenes, sternocleidomastoid, posterior
cervicals, and the pectoralis major and minor muscles.
The patient was also so uncomfortable that he was unable
to lie prone on the chiropractic table, with an
inability to allow his left shoulder to rest level with
his right shoulder.
While standing, the
patient’s arm abduction, flexion and external rotation
were all reduced by at least 50%, with extreme pain and
an observable deficit in the quality of muscular
contraction in the shoulder muscles. The range of motion
of the shoulder joint was measured using a hand-held
goniometer (Graham-Field, Inc.).(9) Eccentric-load
muscle testing was used to evaluate the integrity and
strength of the shoulder’s surrounding muscles.(10) The
initial testing revealed weakness in the deltoids,
rhomboids, trapezius, pectoralis minor, hip flexors and
gluteals bilaterally. Left-side weakness was noted in
the scalenes, sternocleidomastoid, supraspinatus,
infraspinatus, levator scapulae, subscapularis and
pectoralis major.
|
|
|

|
The patient’s spine was assessed for
vertebral subluxations using spinal kinesiopathology,
neuropathophysiology, myopathology, histopathology and
pathophysiology as diagnostic criteria. During the
initial examination, vertebral subluxations were found
at the sacroiliac (SI) joints bilaterally, cervical (C)
vertebrae C1-C3, C5, C7, and thoracic (T) vertebrae T1,
T5-T6, T11-T12.
Treatment was focused on
addressing two main factors: systematically removing the
vertebral subluxations in the patient’s spine using
chiropractic adjustments, and restoring the proper
integrity of the involved musculature using Trigenics.
The overall objectives of treatment were to restore
neuromuscular balance and thus increase the mobility of
the shoulder.
During each treatment, the
chiropractor would only adjust the vertebral
subluxations that were indicated upon motion palpation
and orthopedic assessment.
There were two
possible types of applications for each muscle treated
using Trigenics. The first is known as the Trigenics®
Strengthening (TS) procedure, and this is indicated
where a muscle tests “weak” following eccentric-load
muscle-testing, or where meridian pathways require a
“tonifying” effect in the flow of vital energy along
that meridian channel. The second is called the
Trigenics® Lengthening (TL) procedure, and in this case
was used when a muscle tested “strong” following
eccentric-load muscle testing, yet the associated joint
still demonstrated a reduced range of motion due to
muscle shortness, or when a meridian pathway required a
“sedating” effect in the flow of vital energy along that
meridian channel.(11,12)
The patient underwent
10 trial treatments over a course of eight weeks using a
combination of Trigenics® neuromuscular therapy and
chiropractic adjustments to the spine. The dramatic
results of treatment are presented in Tables 1 through
3.
|
|
|

|
|
|
|
Conclusion The results of this
study suggest that Trigenics® is a very effective treatment
tool used in combination with chiropractic adjustments to
treat a condition known as frozen shoulder syndrome. FSS is
often a very challenging and difficult condition, and
typically requires a lengthy trial of physical therapy. The
results in this
case study are typical when using
Trigenics® technique in conjunction with chiropractic
treatment. Similar results have been demonstrated in treating
a broad spectrum of conditions such as fibromyalgia, cerebral
palsy, rhomboid decelerator dysfunction syndrome, Achilles
paratenonitis, acute inversion ankle reflexogenic strain, and
tendon-itis.(13-19)
Chiropractors wishing to treat
these and other neuromuscular conditions should therefore
consider adding Trigenics® to their therapeutic toolbox. •
References:
- Niel-Asher S. Frozen
shoulder syndrome. Osteopath. Dec 2000/Jan 2001;
21-23.
- Grubbs N. Frozen shoulder syndrome – a
review of literature. JOSPT Sept 1993; 18(3).
- Pal
B. et al. Limitation of joint mobility and shoulder capsulitis
in insulin and non-insulin dependent diabetes mellitus. Br J
of Rheumatology 1986; 25: 147-151.
- Parker JN.
Parker, PM. (editors) The Official Patient’s Sourcebook on
Frozen Shoulder: A Revised and Updated Directory for the
Internet Age. Chapter 1.
- Cluett J. Basic
information about adhesive capsulitis. Medical Multimedia
Group, Inc. June 2, 2003.
www.orthopedics.about.com/cs/frozenshoulder/a/frozenshoulder.htm
- www.frozenshoulder.com
- Stucky A. Keeping your cool
about a frozen shoulder. Part I & II. About Physiotherapy.
www.physicaltherapy.about.com/cs/shoulderinjuries/a/frozen_shoulder.htm
- Reeves B. The natural history of the frozen shoulder.
Scandinavian Journal of Rheumatology 1975; 4:
193-196.
- Magee DJ . Orthopedic physical
assessment. 3rd edition. Toronto: WB Saunders Co., 1997:
Chapter 5.
- Kendall FP. Muscles, Testing and
Function 4th edition. Philadelphia: Lippincott Williams &
Wilkins, 1993.
- Austin AO. Trigenics, Theory
Module I, The Trigenics® Institute of Neuromuscular
Medicine.
- Allan N. Trigenics® Neurophysiology, a
description and preliminary thoughts towards a rationale,
Trigenics® Clinical Applications Module III, 1st edition;
48-49.
- DeFinney J. Achilles paratenonitis: A
therapeutic case study. Canadian Chiropractor Oct
2001.
- Pisarek S. Trigenics: A new paradigm in
soft tissue therapeutics – rhomboid decelerator dysfunction
syndrome. Canadian Chiropractor Feb 2001; 6(1):18, 41.
- Pisarek S. Acute inversion ankle reflexogenic
strain. Canadian Chiropractor September 2002; 7(4).
- Guenette C. Soft tissue approach to
fibromyalgia: A new treatment protocol combining chiropractic
with the Trigenics® technique. Canadian Chiropractor Feb 2003;
8(1).
- Guenette C. Rotator cuff tendonitis – case
study: An application of the Trigenics® technique. Canadian
Chiropractor Feb 2002.
- Hooper K. Advanced
neuromuscular medicine for soft-tissue conditions and athletic
enhancement: Gluteus medius strain in a competitive triathlete
– A case study. Dynamic Chiropractic Aug 16, 2003; 21(17).
- McAllister P. Cerebral palsy – Case study.
Canadian Chiropractor May 2003; 8(3);
18-23.
|
|